asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation resulting from immune response activation leads to swelling and increased mucus production, causing narrowed airways and difficulty breathing.

• Secondary mechanism: Bronchial hyperresponsiveness, where airways overreact to triggers (allergens, irritants), results in smooth muscle contraction and further narrowing of the airways.

• Key complication: Chronic inflammation can lead to airway remodeling, causing persistent changes in airway structure and function, potentially worsening control and increasing frequency of asthma attacks.

Patient Profile

Demographics:

32-year-old female, school teacher

History:

• Key past medical history: Diagnosed with asthma at age 18, occasional acute bronchitis

• Current medications: Inhaled corticosteroid (Fluticasone), Albuterol inhaler as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath and wheezing

• Key symptoms: Persistent cough, chest tightness, fatigue, mild anxiety

• Vital signs: Temperature 98.6°F, Heart rate 96 bpm, Respiratory rate 24 breaths/min, Blood pressure 128/84 mmHg, Oxygen saturation 92% on room air

Section 1

The initial assessment reveals that the patient's respiratory status is deteriorating. Upon auscultation, there are diffuse bilateral wheezes, indicating widespread airway constriction. Her peak expiratory flow rate (PEFR) is measured at 60% of her personal best, suggesting a significant reduction in airflow. The patient reports that her symptoms have progressively worsened over the past few days, despite adherence to her asthma action plan and increased use of her Albuterol inhaler. The patient's fatigue and mild anxiety are also noted as contributing factors to her overall discomfort and decreased ability to participate in her daily activities.

Given her worsening condition, the medical team orders a chest X-ray and arterial blood gases (ABG) to further evaluate her respiratory status and rule out complications such as pneumonia or pneumothorax. The chest X-ray shows no signs of infection or other acute thoracic abnormalities. However, ABG results indicate respiratory acidosis, with a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 68 mmHg, suggesting inadequate ventilation and hypoxemia. These findings corroborate the clinical picture of a moderate asthma exacerbation that is not fully responsive to her current treatment regimen.

The next step involves adjusting her management plan to address the acute exacerbation and prevent further deterioration. The healthcare team considers introducing systemic corticosteroids to reduce airway inflammation and improve her respiratory function. Additionally, they discuss the potential need for nebulized bronchodilators to provide more consistent and effective relief than her handheld inhaler. Close monitoring of her response to these interventions, as well as regular reassessment of her vital signs and oxygen saturation, will be crucial in guiding further treatment and preventing the development of more severe complications.

Section 2

As the healthcare team begins the adjusted management plan, the patient is started on systemic corticosteroids and nebulized bronchodilator therapy. Initially, there is a slight improvement in her peak expiratory flow rate, which rises to 65% of her personal best, indicating a modest response to treatment. However, during the next assessment, her respiratory rate remains elevated at 28 breaths per minute, and she continues to exhibit diffuse bilateral wheezing upon auscultation. Her oxygen saturation remains at 90% on 2 liters of supplemental oxygen via nasal cannula, suggesting persistent hypoxemia despite the interventions.

Concerned about the potential development of further complications, such as worsening ventilation-perfusion mismatch, the team decides to obtain a repeat arterial blood gas. The new ABG results show a pH of 7.30, PaCO2 of 50 mmHg, and PaO2 of 64 mmHg, indicating a slight progression of respiratory acidosis and hypoxemia. This suggests that the patient's ventilation is still compromised, and her condition may be progressing towards a more severe exacerbation. The healthcare team considers the necessity of escalating care, which may include increasing the intensity of bronchodilator therapy and considering non-invasive positive pressure ventilation to improve her respiratory status.

The patient's increased fatigue and anxiety are also addressed, with the team providing reassurance and support to help alleviate her distress. Efforts are made to ensure she is comfortable and that her environment is conducive to rest. As the team continues to monitor her closely, the focus remains on preventing further deterioration while evaluating the need for additional interventions. This juncture presents a critical opportunity for clinical reasoning, as the team weighs potential treatment adjustments and anticipates possible complications, aiming to stabilize the patient's condition and improve her respiratory function.

Section 3

The healthcare team decides to focus on the patient's response to the intensified interventions. After increasing the frequency of nebulized bronchodilator therapy and introducing non-invasive positive pressure ventilation (NIPPV) via a bilevel positive airway pressure (BiPAP) machine, the team closely monitors the patient's clinical parameters. Over the next few hours, there is a notable improvement in her work of breathing. Her respiratory rate decreases to 22 breaths per minute, a sign that the NIPPV is helping to alleviate some of the ventilatory demand. However, despite these improvements, her oxygen saturation only marginally increases to 92% on BiPAP with 40% oxygen, indicating that oxygenation is still suboptimal.

In parallel, the team conducts a repeat assessment and notes that while the wheezing remains present, it has slightly diminished in intensity. However, the patient continues to exhibit accessory muscle use and mild retractions, suggesting that the respiratory muscles are still under significant strain. The patient's anxiety levels have decreased somewhat due to improved communication and reassurance from the healthcare team, but her fatigue persists.

Recognizing the importance of ongoing assessment and the potential for new complications, the team decides to repeat the arterial blood gas analysis to evaluate the effectiveness of the current management. The new ABG results show a pH of 7.35, PaCO2 of 48 mmHg, and PaO2 of 70 mmHg. This indicates a slight improvement in her respiratory acidosis and hypoxemia, yet still signifies the need for continued vigilance. The team contemplates further adjustments to her treatment regimen, considering the possibility of corticosteroid tapering as her condition stabilizes, while remaining alert to any signs of deterioration that may necessitate more aggressive interventions.

Section 4

As the team continues to monitor the patient's response to the intensified interventions, they notice a change in her status. Over the next few hours, the patient begins to exhibit signs of increased respiratory distress despite the ongoing support with BiPAP. Her respiratory rate begins to climb again, reaching 28 breaths per minute, and she shows increased effort in her breathing with more pronounced accessory muscle use and retractions. This change in her clinical status prompts further investigation into potential new complications that might be affecting her recovery.

A chest X-ray is ordered to rule out any underlying issues that may be contributing to her persistent symptoms. The results reveal the development of a right-sided pneumothorax, a complication that can arise from both the underlying severe asthma and the use of positive pressure ventilation. This finding correlates with the sudden increase in respiratory distress and suggests that the pneumothorax may be compromising her lung function and oxygenation further.

In light of this new complication, the healthcare team quickly initiates a plan to address the pneumothorax. A chest tube insertion is considered to relieve the pressure and allow the lung to re-expand, aiming to improve her respiratory status and oxygenation. The team also re-evaluates her medication regimen, ensuring that the bronchodilator therapy and corticosteroids are optimized to manage her asthma effectively while preparing for the potential need for more invasive interventions if her condition does not improve. This situation underscores the importance of dynamic clinical reasoning and adaptability in response to evolving patient needs.

Section 5

As the healthcare team prepares for the chest tube insertion, they conduct a thorough initial assessment to establish a baseline before the procedure. The patient is visibly anxious, which is understandable given her current respiratory distress. Her vital signs reveal a heart rate of 110 beats per minute, blood pressure of 145/85 mmHg, and an oxygen saturation of 88% on BiPAP, indicating insufficient oxygenation. The patient continues to exhibit tachypnea with a respiratory rate of 30 breaths per minute, and auscultation of the lungs reveals diminished breath sounds on the right side, consistent with the pneumothorax diagnosis. While her skin remains warm and dry, she appears diaphoretic, further signaling her increased work of breathing.

In conjunction with the chest tube insertion, the team orders a comprehensive metabolic panel and arterial blood gas analysis to further evaluate the patient’s respiratory and metabolic status. The ABG results show a pH of 7.32, PaCO2 of 50 mmHg, PaO2 of 60 mmHg, and HCO3- of 24 mEq/L, indicating respiratory acidosis with hypoxemia. These findings suggest that despite the BiPAP support, the patient is unable to adequately ventilate and exchange gases, likely exacerbated by the pneumothorax. The metabolic panel reveals no significant electrolyte imbalances, which is reassuring as the team focuses on correcting her respiratory issues.

Following the chest tube insertion, the team closely monitors the patient’s response to the intervention, hoping to see an improvement in her respiratory effort and gas exchange. As the lung re-expands, they anticipate a gradual improvement in her oxygenation and a reduction in her respiratory rate. The healthcare provider's ability to integrate these assessment findings and diagnostic results into their clinical reasoning will be crucial in guiding the next steps of her treatment plan, ensuring that any potential new complications are swiftly identified and addressed.